Richard Pizzi is editor of The Hospitalist. He has been an editor at Frontline Medical Communications since 2015, and previously served as editor of MDedge publications Hospitalist News and ID Practitioner. He has also worked as an editor and in editorial management roles for HIMSS Media, MedTech Media, and the American Association for Clinical Chemistry. Follow him on Twitter @richpizzi
News
HIV drug abacavir linked with higher CVD risk
The antiretroviral drug abacavir was associated with a more than twofold increased risk of cardiovascular disease in a cohort study of 8,154 HIV-...
News
Efavirenz linked with higher bone mass in children with HIV
Switching HIV-infected South African children from ritonavir-boosted lopinavir (LPV/r) to efavirenz (EFV)-based antiretroviral therapy improved...
News
HIV research update: Early February 2016
A great volume of HIV and AIDS research enters the medical literature every month. It’s difficult to monitor everything, so here’s a quick look at...
News
Study: Hospitals with EHRs reduce patient harm
Cardiovascular, surgery, and pneumonia patients at hospitals with a fully electronic health record (EHR) system experienced lower rates of in-...
News
Borrelia mayonii is new cause of Lyme disease variant
A new species of Borrelia appears to cause a variant of Lyme disease.
News
Chlorhexidine baths help hospitals control extensively drug-resistant pathogen
When faced with an outbreak of the extensively drug-resistant pathogen Acinetobacter baumannii (XDR-Ab), hospitals must improve their patient...
News
HIV research update: Late January 2016
A great volume of HIV and AIDS research enters the medical literature every month. It’s difficult to monitor everything, so here’s a quick look at...
News
Hepatitis B vaccine protection lasts 30 years
Ninety percent of patients in a 1981 hepatitis B vaccine trial still had evidence of immune protection 30 years later, according to a study in the...
News
Ebola research update: January 2016
The struggle to defeat Ebola virus disease continues globally, although it may not always make the headlines. To catch up on what you may have...
News
Zika virus lessons from Colombia
Two recent research letters from Colombia offer U.S. clinicians insight into the challenges of battling Zika virus on the front lines of the...
News
FDA approves new treatment for chronic HCV genotypes 1 and 4
The U.S. Food and Drug Administration has approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic...
News
Experts: WHO failing to lead on Zika pandemic
The World Health Organization has failed to act decisively in response to the growing the Zika virus outbreak, global health experts said in a...
News
Trial results for hepatitis C antivirals not generalizable to coinfected HIV/HCV patients
Clinical trial results for direct-acting antivirals against hepatitis C virus (HCV) may have limited generalizability for patients coinfected with...
News
New population testing algorithm may improve hepatitis C surveillance
An algorithm that accurately estimates the population-level incidence of hepatitis C infection may boost public health efforts in high-risk...